Literature DB >> 15602021

Risk of myocardial infarction and stroke after acute infection or vaccination.

Liam Smeeth1, Sara L Thomas, Andrew J Hall, Richard Hubbard, Paddy Farrington, Patrick Vallance.   

Abstract

BACKGROUND: There is evidence that chronic inflammation may promote atherosclerotic disease. We tested the hypothesis that acute infection and vaccination increase the short-term risk of vascular events.
METHODS: We undertook within-person comparisons, using the case-series method, to study the risks of myocardial infarction and stroke after common vaccinations and naturally occurring infections. The study was based on the United Kingdom General Practice Research Database, which contains computerized medical records of more than 5 million patients.
RESULTS: A total of 20,486 persons with a first myocardial infarction and 19,063 persons with a first stroke who received influenza vaccine were included in the analysis. There was no increase in the risk of myocardial infarction or stroke in the period after influenza, tetanus, or pneumococcal vaccination. However, the risks of both events were substantially higher after a diagnosis of systemic respiratory tract infection and were highest during the first three days (incidence ratio for myocardial infarction, 4.95; 95 percent confidence interval, 4.43 to 5.53; incidence ratio for stroke, 3.19; 95 percent confidence interval, 2.81 to 3.62). The risks then gradually fell during the following weeks. The risks were raised significantly but to a lesser degree after a diagnosis of urinary tract infection. The findings for recurrent myocardial infarctions and stroke were similar to those for first events.
CONCLUSIONS: Our findings provide support for the concept that acute infections are associated with a transient increase in the risk of vascular events. By contrast, influenza, tetanus, and pneumococcal vaccinations do not produce a detectable increase in the risk of vascular events. Copyright 2004 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15602021     DOI: 10.1056/NEJMoa041747

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  384 in total

1.  Pharmacoepidemiology.

Authors:  Stephen J W Evans
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

Review 2.  Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.

Authors:  Tuhina Neogi; Jacob George; Sushma Rekhraj; Allan D Struthers; Hyon Choi; Robert A Terkeltaub
Journal:  Arthritis Rheum       Date:  2012-02

Review 3.  Short-term vascular risk: time to take notice?

Authors:  Liam Smeeth; Aroon D Hingorani
Journal:  Nat Rev Cardiol       Date:  2010-05-04       Impact factor: 32.419

Review 4.  Infection and Stroke: an Update on Recent Progress.

Authors:  Eliza C Miller; Mitchell S V Elkind
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

5.  Seasonal Influenza Infections and Cardiovascular Disease Mortality.

Authors:  Jennifer L Nguyen; Wan Yang; Kazuhiko Ito; Thomas D Matte; Jeffrey Shaman; Patrick L Kinney
Journal:  JAMA Cardiol       Date:  2016-06-01       Impact factor: 14.676

6.  Recent respiratory infection and the risk of myocardial infarction.

Authors:  T C Clayton; N E Capps; N G Stephens; J A Wedzicha; T W Meade
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

7.  Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen Stroke Study (LuSSt).

Authors:  Frederick Palm; Michael Dos Santos; Christian Urbanek; Matthias Greulich; Kathrin Zimmer; Anton Safer; Armin Jürgen Grau; Heiko Becher
Journal:  Eur J Epidemiol       Date:  2013-02-06       Impact factor: 8.082

8.  Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.

Authors:  Antonella Zambon; Hernan Polo Friz; Paolo Contiero; Giovanni Corrao
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults.

Authors:  Maryam Keshtkar-Jahromi; Min Ouyang; Marzieh Keshtkarjahromi; Samah Almed; Huifen Li; Jeremy D Walston; Rebeca Rios; Sean X Leng
Journal:  Vaccine       Date:  2018-03-13       Impact factor: 3.641

10.  Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study.

Authors:  Hamid Mohseni; Amit Kiran; Reza Khorshidi; Kazem Rahimi
Journal:  Eur Heart J       Date:  2017-02-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.